(Q39799061)

14 September 2017

1 reference

title

Bromocriptine in the treatment of hypogonadism and male impotence (English)

1 reference

14 September 2017

Bromocriptine in the Treatment of Hypogonadism and Male Impotence (English)

1 reference

10.2165/00003495-197917050-00004

Crossref

DOI

https://api.crossref.org/works/10.2165/00003495-197917050-00004

12 April 2023

1 reference

C. M. March

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A378650

12 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=378650

12 April 2023

publication date

1 May 1979

1 reference

14 September 2017

1 reference

14 September 2017

17

1 reference

14 September 2017

5

1 reference

14 September 2017

349-358

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-197917050-00004

14 September 2017

0 references

cites work

Bromocriptine for induction of ovulation in normoprolactinaemic post-pill anovulation

1 reference

12 December 2020

Prolactin-Secreting Tumors and Hypogonadism in 22 Men

1 reference

12 December 2020

Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells

1 reference

12 December 2020

Galactorrhea-amenorrhea due to primary hypothyroidism

1 reference

12 December 2020

Detection, evaluation, and treatment of pituitary microadenomas in patients with galactorrhea and amenorrhea

1 reference

12 December 2020

Treatment of hyperprolactinemic amenorrhea by intermittent administration of bromocryptine (CB 154)

1 reference

12 December 2020

Ovarian response to exogenous gonadotropins in women with elevated serum prolactin

1 reference

12 December 2020

Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor

1 reference

12 December 2020

The activating effect of L-dopa treatment on sexual functions and its experimental background.

1 reference

12 December 2020

Bromocriptine treatment of secondary amenorrhoea

1 reference

12 December 2020

Adenohypophysis:prolactin

1 reference

12 December 2020

Ovulation induction in amenorrheic women

1 reference

12 December 2020

Induction of ovulation in infertile women with pituitary tumors

1 reference

12 December 2020

Ovarian hyperstimulation syndrome. Report of a case with notes on pathogenesis and treatment

1 reference

12 December 2020

The influence of the prolactin inhibitor bromocriptin (CB 154) on human luteal function in vivo

1 reference

12 December 2020

Bromocriptine in impotence

1 reference

12 December 2020

Quintuplet gestation after ovulation induction with menopausal gonadotropins and pituitary luteinizing hormone

1 reference

12 December 2020

Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154)

1 reference

12 December 2020

Bromocriptine in impotence.

1 reference

12 December 2020

Amenorrhea, hyperprolactinemia and pituitary enlargement secondary to primary hypothyroidism. Successful treatment with thyroid replacement

1 reference

12 December 2020

Induction of menstruation with bromocryptine in patients with euprolactinemic amenorrhea

1 reference

12 December 2020

The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).

1 reference

12 December 2020

Successful treatment of galactorrhoea and amenorrhoea and subsequent restoration of ovarian function by a new ergot alkaloid 2-brom-alpha-ergocryptine.

1 reference

12 December 2020

Effect of clomiphene citrate upon amount and duration of human menopausal gonadotropin therapy

1 reference

12 December 2020

A possible role for prolactin in control of steroid secretion by the human Graafian follicle

1 reference

12 December 2020

Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea

1 reference

12 December 2020

Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.

1 reference

12 December 2020

Hyperprolactinemia associated with empty sella syndrome

1 reference

12 December 2020

Idiopathic Hypogonadotrophic Hypogonadal Primary Amenorrhea*

1 reference

12 December 2020

Outcome of pregnancy in mothers given bromocriptine

1 reference

12 December 2020

Proceedings: Endocrine profiles in amenorrhoea: incidence and significance of hyperprolactinaemia

1 reference

12 December 2020

Bromocriptine treatment of hyperprolactinaemic hypogonadism

1 reference

12 December 2020

Galactorrhea and pituitary tumors in postpill and non-postpill secondary amenorrhea

1 reference

12 December 2020

Normalization of Visual Fields Following Bromocriptine Treatment in Hyperprolactinemic Patients with Visual Field Constriction

1 reference

12 December 2020

Treatment Of Functional Amenorrhea-Galactorrhea With 2-Bromoergocryptine

1 reference

12 December 2020

Hyperprolactinemic male infertility

1 reference

12 December 2020

Classification of Secondary Amenorrhea Based on Distinct Hormonal Patterns

1 reference

12 December 2020

Bromocryptine therapy in cases of amenorrhea-galactorrhea

1 reference

12 December 2020

Pituitary tumors and pregnancy

1 reference

12 December 2020

Suppression of pituitary tumor growth and function by ergot alkaloids.

1 reference

12 December 2020

Bromocriptine for male infertility

1 reference

12 December 2020

The significance of glactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea

1 reference

12 December 2020

Clinical categorization of patients with secondary amenorrhea using progesterone-induced uterine bleeding and measurement of serum gonadotropin levels

1 reference

12 December 2020

Drugs that affect the breast and lactation

1 reference

12 December 2020

Prediction of Response to Ergocryptine In the Galactorrhea-Amenorrhea Syndrome

1 reference

12 December 2020

Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man

1 reference

12 December 2020

Clinical Response to CB-154 and the Pituitary Response to Thyrotropin-Releasing Hormone-Gonadotropin-Releasing Hormone in Patients with Galactorrhea-Amenorrhea

1 reference

12 December 2020

Clinical and hormonal response to bromocriptin (CB-154) in the galactorrhea syndromes

1 reference

12 December 2020

Inhibition of cyclic gonadotropin secretion by endogenous human prolactin

1 reference

12 December 2020

Conservative management of a pituitary tumor during pregnancy following induction of ovulation with gonadotropins

1 reference

12 December 2020

10.2165/00003495-197917050-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

14 September 2017

1027325233

0 references

Fatcat ID

release_ctt7nk6ecvdvpmmdple3l6ypaq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ctt7nk6ecvdvpmmdple3l6ypaq

24 November 2022

mapped directly with Wikidata item

1 reference